View in EDS HTML Full Text PDF Full Text

Impact of DNA methylation on the recurrence risk of stage I non-small cell lung cancer with EGFR mutations.

Saved in:
Bibliographic Details
Title: Impact of DNA methylation on the recurrence risk of stage I non-small cell lung cancer with EGFR mutations.
Authors: Li Y; Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China.; Hunan Key Laboratory of Early Diagnosis and Precise Treatment of Lung Cancer, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China., Yang Z; Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China.; Hunan Key Laboratory of Early Diagnosis and Precise Treatment of Lung Cancer, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China., Wu F; Department of Oncology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China., Liang Q; Department of Pathology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China., Herman JG; UPMC Hillman Cancer Center, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Brock MV; Department of Surgery, The Sidney Kimmel Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Liu W; Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China.; Hunan Key Laboratory of Early Diagnosis and Precise Treatment of Lung Cancer, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China., Yu F; Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China.; Hunan Key Laboratory of Early Diagnosis and Precise Treatment of Lung Cancer, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China., He X; Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China. hexuehuxi@csu.edu.cn.; Hunan Key Laboratory of Early Diagnosis and Precise Treatment of Lung Cancer, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China. hexuehuxi@csu.edu.cn., Chen C; Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China. chenchen1981412@csu.edu.cn.; Hunan Key Laboratory of Early Diagnosis and Precise Treatment of Lung Cancer, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China. chenchen1981412@csu.edu.cn.
Source: Clinical epigenetics [Clin Epigenetics] 2025 Jun 02; Vol. 17 (1), pp. 90. Date of Electronic Publication: 2025 Jun 02.
Publication Type: Journal Article
Journal Info: Publisher: Biomed Central Country of Publication: Germany NLM ID: 101516977 Publication Model: Electronic Cited Medium: Internet ISSN: 1868-7083 (Electronic) Linking ISSN: 18687075 NLM ISO Abbreviation: Clin Epigenetics Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40457471
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Impact of DNA methylation on the recurrence risk of stage I non-small cell lung cancer with EGFR mutations.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Li+Y%22">Li Y</searchLink>; Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China.; Hunan Key Laboratory of Early Diagnosis and Precise Treatment of Lung Cancer, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Yang+Z%22">Yang Z</searchLink>; Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China.; Hunan Key Laboratory of Early Diagnosis and Precise Treatment of Lung Cancer, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Wu+F%22">Wu F</searchLink>; Department of Oncology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Liang+Q%22">Liang Q</searchLink>; Department of Pathology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Herman+JG%22">Herman JG</searchLink>; UPMC Hillman Cancer Center, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.<br /><searchLink fieldCode="AU" term="%22Brock+MV%22">Brock MV</searchLink>; Department of Surgery, The Sidney Kimmel Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Liu+W%22">Liu W</searchLink>; Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China.; Hunan Key Laboratory of Early Diagnosis and Precise Treatment of Lung Cancer, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Yu+F%22">Yu F</searchLink>; Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China.; Hunan Key Laboratory of Early Diagnosis and Precise Treatment of Lung Cancer, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22He+X%22">He X</searchLink>; Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China. hexuehuxi@csu.edu.cn.; Hunan Key Laboratory of Early Diagnosis and Precise Treatment of Lung Cancer, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China. hexuehuxi@csu.edu.cn.<br /><searchLink fieldCode="AU" term="%22Chen+C%22">Chen C</searchLink>; Department of Thoracic Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China. chenchen1981412@csu.edu.cn.; Hunan Key Laboratory of Early Diagnosis and Precise Treatment of Lung Cancer, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China. chenchen1981412@csu.edu.cn.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101516977%22">Clinical epigenetics</searchLink> [Clin Epigenetics] 2025 Jun 02; Vol. 17 (1), pp. 90. <i>Date of Electronic Publication: </i>2025 Jun 02.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Biomed+Central%22">Biomed Central </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>101516977 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1868-7083 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2218687075%22">18687075 </searchLink><i>NLM ISO Abbreviation: </i>Clin Epigenetics <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40457471
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1186/s13148-025-01899-9
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 90
    Titles:
      – TitleFull: Impact of DNA methylation on the recurrence risk of stage I non-small cell lung cancer with EGFR mutations.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Li Y
      – PersonEntity:
          Name:
            NameFull: Yang Z
      – PersonEntity:
          Name:
            NameFull: Wu F
      – PersonEntity:
          Name:
            NameFull: Liang Q
      – PersonEntity:
          Name:
            NameFull: Herman JG
      – PersonEntity:
          Name:
            NameFull: Brock MV
      – PersonEntity:
          Name:
            NameFull: Liu W
      – PersonEntity:
          Name:
            NameFull: Yu F
      – PersonEntity:
          Name:
            NameFull: He X
      – PersonEntity:
          Name:
            NameFull: Chen C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 06
              Text: 2025 Jun 02
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1868-7083
          Numbering:
            – Type: volume
              Value: 17
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Clinical epigenetics
              Type: main
ResultId 1